Edgestream Partners »

BioCryst Pharmaceuticals shares owned by Edgestream Partners

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Edgestream Partners from 13F filings

Historical chart of Edgestream Partners investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Edgestream Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Edgestream Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $615k 61k 10.00
2023-06-30 $216k 31k 7.04

More positions owned by Edgestream Partners

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
NiSource (NI)
Dt Midstream Common Stock (DTM)
Antero Midstream Corp antero midstream (AM)
Toll Brothers (TOL)
Atmos Energy Corporation (ATO)
Northern Trust Corporation (NTRS)
Popular Com New (BPOP)
Aptar (ATR)
White Mountains Insurance Gp (WTM)
Ameren Corporation (AEE)

View all positions for Edgestream Partners

Top funds holding BioCryst Pharmaceuticals

BlackRock
RA Capital Management
Deerfield Management Company
State Street Corporation
Vanguard Capital Management
Vanguard Portfolio Management
TCG Crossover Management
Perceptive Advisors
Jupiter Topco
Henderson Group
Vestal Point Capital
Two Sigma Investments
Geode Capital Management
Standard Life Aberdeen
UBS Group

View all funds holding BioCryst Pharmaceuticals